Therorna
Clinical trials sponsored by Therorna, explained in plain language.
-
Revolutionary In-Body CAR-T therapy targets autoimmune diseases
Disease control Recruiting nowThis early-phase study tests a new treatment called TI-0032-III for people with severe autoimmune diseases like lupus and Sjögren's syndrome that haven't improved with standard care. The treatment uses a special injection to create CAR-T cells inside the body, which then target a…
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New shot targets HPV-16 cancers in early human trial
Disease control Recruiting nowThis early-stage study tests a new injection called TI-0093 in 12 adults with HPV-16 positive cancers (like head, neck, or cervical cancer) that returned or spread. The main goals are to check safety, find the best dose, and see how the body responds. It is not a cure but aims to…
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated May 08, 2026 12:01 UTC